Pharmalittle: Drug makers to raise prices in January; Novartis names a new oncology chief, again

Good morning, everyone, and how are you today? We are doing just fine, thank you, despite a creaky laptop that seems to require more cups of stimulation than we do. Nonetheless, we are forging ahead with plans to hunt for interesting items and making new contacts. Meanwhile, here is the latest menu of tidbits to help you with your own progress today. We hope the journey goes well and, as always, do keep in touch …

Nearly 30 drug makers have taken steps to raise U.S. prices of their medicines in January, ending a self-declared halt to increases made under pressure from the Trump administration, according to Reuters. Twenty-eight companies filed notifications with California agencies in early November disclosing that they planned to raise prices in 60 days or longer. Under a state law passed last year, companies are required to notify payers in California if they intend to raise the U.S. list price on any drug by more than 16 percent over a two-year period.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!